Skip to content

Ehlers Danlos Syndrome Type 4 C0268338

Published: July 22, 2026Updated: August 20, 2026

A vascular form of Ehlers-Danlos syndrome affecting collagen in blood vessels and organs. Patients face increased risk of arterial and organ rupture. Requires careful medical supervision and preventive strategies throughout life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Easy bruising

(cardiovascular)

Peripheral edema

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Vascular and Organ Surveillance

Regular imaging surveillance of arteries, organs, and hollow viscus structures to detect and monitor for potential complications such as aneurysms or rupture risk.

monitoring
3

Activity Restriction and Precaution

Avoidance of contact sports, heavy lifting, and activities that increase intraocular or arterial pressure to minimize rupture risk.

lifestyle

Additional treatment options

Cardiovascular Risk Management

Blood pressure control and cardiovascular risk factor modification using appropriate medications while avoiding agents that may increase arterial stress.

medication

Psychological Support and Counseling

Mental health support to address anxiety, trauma concerns, and quality of life issues associated with living with a high-risk vascular condition.

psychological

Elective Surgical Intervention

Planned surgical procedures only when absolutely necessary, performed by experienced teams with appropriate precautions for tissue fragility.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ehlers Danlos Syndrome Type 4 C0268338?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Ehlers Danlos Syndrome Type 4 C0268338. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy